Search research articles
Contact Us
Filters
Showing results (191-200 of 525) with videos related to
Page
of 53
Sort By:
Plos Pathogens
|
September 13, 2011
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies
Ben-Jiang Ma, S Munir Alam, Eden P Go, et al.
Journal of Virology
|
August 6, 2010
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys
Jinyan Liu, Brandon F Keele, Hui Li, et al.
The Journal of Infectious Diseases
|
April 1, 2011
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers
Paul Spearman, Michelle A Lally, Marnie Elizaga, et al.
Scientific Reports
|
March 6, 2021
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
Merricka C Livingstone, Alexis A Bitzer, Alish Giri, et al.
Frontiers in Immunology
|
March 13, 2026
Early rise in nasal secretory IgA associated with shorter duration of SARS-CoV-2 virus shedding in an acute infection cohort
Caroline Brackett, Lu Zhang, Bich T N Do, et al.
Journal of Pharmaceutical Sciences
|
July 27, 2019
Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity
Bruce A Kerwin, Chelsey Bennett, Yan Brodsky, et al.
Mucosal Immunology
|
January 10, 2013
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life
N L Yates, A R Stacey, T L Nolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable
Stephen C De Rosa, Evan P Thomas, John Bui, et al.
Frontiers in Immunology
|
March 30, 2026
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702
Ferdinando Menezes, Shiyu Chen, Nicole Grunenberg, et al.
JCI Insight
|
April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response
James J Knox, Marcus Buggert, Lela Kardava, et al.
Page
of 53
Search research articles
Search
Showing results (191-200 of 525) with videos related to
Sort By:
Page
of 53
Plos Pathogens
|
September 13, 2011
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies
Ben-Jiang Ma, S Munir Alam, Eden P Go, et al.
Journal of Virology
|
August 6, 2010
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys
Jinyan Liu, Brandon F Keele, Hui Li, et al.
The Journal of Infectious Diseases
|
April 1, 2011
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers
Paul Spearman, Michelle A Lally, Marnie Elizaga, et al.
Scientific Reports
|
March 6, 2021
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
Merricka C Livingstone, Alexis A Bitzer, Alish Giri, et al.
Frontiers in Immunology
|
March 13, 2026
Early rise in nasal secretory IgA associated with shorter duration of SARS-CoV-2 virus shedding in an acute infection cohort
Caroline Brackett, Lu Zhang, Bich T N Do, et al.
Journal of Pharmaceutical Sciences
|
July 27, 2019
Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity
Bruce A Kerwin, Chelsey Bennett, Yan Brodsky, et al.
Mucosal Immunology
|
January 10, 2013
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life
N L Yates, A R Stacey, T L Nolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 17, 2011
HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable
Stephen C De Rosa, Evan P Thomas, John Bui, et al.
Frontiers in Immunology
|
March 30, 2026
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702
Ferdinando Menezes, Shiyu Chen, Nicole Grunenberg, et al.
JCI Insight
|
April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response
James J Knox, Marcus Buggert, Lela Kardava, et al.
Page
of 53